<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39445120</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2688-1152</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of the American College of Emergency Physicians open</Title><ISOAbbreviation>J Am Coll Emerg Physicians Open</ISOAbbreviation></Journal><ArticleTitle>Evaluation of an emergency department-based approach to reduce subsequent opioid overdoses.</ArticleTitle><Pagination><StartPage>e13304</StartPage><MedlinePgn>e13304</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e13304</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/emp2.13304</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">The purpose of this study was to determine the association of a multi-pronged treatment program in emergency department (ED) patients with an acute presentation of opioid use disorder (OUD) on the rate of subsequent opioid overdose (OD). This approach included ED-initiated take-home naloxone, prescription buprenorphine, and an ED-based peer support and recovery program.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This was a retrospective observational analysis of adult patients presenting to the ED at a large urban hospital system from November 1, 2017 to March 17, 2023. Patients with an ED discharge diagnosis of OD or OUD were included. Outcomes determined were subsequent 90-day OD and 180-day OD death. Post hoc analyses were performed to identify intervention utilization throughout the study period including the COVID-19 pandemic as well as ED characteristics associated with subsequent OD and OD death. Statistical comparisons were made using logistic regression and chi-squared test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 2634 patients presented to the ED with an opioid OD or diagnosis of OUD. Subsequent 90-day OD decreased significantly over time (11.5%-2.3%, odds ratio [OR] 0.85, confidence interval [CI] 0.82-0.89). No single intervention was independently associated with 90-day OD or 180-day OD death. Resource utilization was stable during the COVID-19 pandemic and increased afterward. A higher buprenorphine fill-rate among all patients and the Back race subgroup was associated with a decrease in 90-day OD.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Subsequent OD and OD death decreased over time after implementation of a multi-pronged treatment program to ED patients with OUD. No single intervention was associated with a decrease of subsequent OD or OD death.</AbstractText><CopyrightInformation>© 2024 The Author(s). Journal of the American College of Emergency Physicians Open published by Wiley Periodicals LLC on behalf of American College of Emergency Physicians.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reed</LastName><ForeName>Eric N</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine The MetroHealth System Case Western Reserve University Cleveland Ohio USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papp</LastName><ForeName>Joan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine The MetroHealth System Case Western Reserve University Cleveland Ohio USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Yesol</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine The MetroHealth System Case Western Reserve University Cleveland Ohio USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LeVine</LastName><ForeName>Kellie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine The MetroHealth System Case Western Reserve University Cleveland Ohio USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarabichi</LastName><ForeName>Yasir</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine The MetroHealth System Case Western Reserve University Cleveland Ohio USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastian</LastName><ForeName>Estella</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine The MetroHealth System Case Western Reserve University Cleveland Ohio USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pollock</LastName><ForeName>Kailee</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine The MetroHealth System Case Western Reserve University Cleveland Ohio USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Lance D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine The MetroHealth System Case Western Reserve University Cleveland Ohio USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siff</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine The MetroHealth System Case Western Reserve University Cleveland Ohio USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piktel</LastName><ForeName>Joseph S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine The MetroHealth System Case Western Reserve University Cleveland Ohio USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Coll Emerg Physicians Open</MedlineTA><NlmUniqueID>101764779</NlmUniqueID><ISSNLinking>2688-1152</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>16</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>4</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39445120</ArticleId><ArticleId IdType="pmc">PMC11496383</ArticleId><ArticleId IdType="doi">10.1002/emp2.13304</ArticleId><ArticleId IdType="pii">EMP213304</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Spencer MR, Miniño AM, Warner M. Drug overdose deaths in the United States, 2001–2021. NCHS Data Brief. 2022(457):1‐8.</Citation><ArticleIdList><ArticleId IdType="pubmed">36598401</ArticleId></ArticleIdList></Reference><Reference><Citation>Balio CP, Wiley KK Jr, Greene MS, Vest JR. Opioid‐related emergency department encounters: patient, encounter, and community characteristics associated with repeated encounters. Ann Emerg Med. 2020;75:568‐575. doi:10.1016/j.annemergmed.2019.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2019.12.005</ArticleId><ArticleId IdType="pmc">PMC10929732</ArticleId><ArticleId IdType="pubmed">31983498</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Scholl L, Hoots B, Seth P. Nonfatal drug and polydrug overdoses treated in emergency departments—29 states, 2018–2019. MMWR Morb Mortal Wkly Rep. 2020;69(34):1149‐1155. doi:10.15585/mmwr.mm6934a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6934a1</ArticleId><ArticleId IdType="pmc">PMC7451974</ArticleId><ArticleId IdType="pubmed">32853194</ArticleId></ArticleIdList></Reference><Reference><Citation>Krawczyk N, Eisenberg M, Schneider KE, et al. Predictors of overdose death among high‐risk emergency department patients with substance‐related encounters: a data linkage cohort study. Ann Emerg Med. 2020;75(1):1‐12. doi:10.1016/j.annemergmed.2019.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2019.07.014</ArticleId><ArticleId IdType="pmc">PMC6928412</ArticleId><ArticleId IdType="pubmed">31515181</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagley SM, Larochelle MR, Xuan Z, et al. Characteristics and receipt of medication treatment among young adults who experience a nonfatal opioid‐related overdose. Ann Emerg Med. 2020;75(1):29‐38. doi:10.1016/j.annemergmed.2019.07.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2019.07.030</ArticleId><ArticleId IdType="pmc">PMC7953238</ArticleId><ArticleId IdType="pubmed">31591014</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner SG, Baker O, Bernson D, Schuur JD. One‐year mortality of patients after emergency department treatment for nonfatal opioid overdose. Ann Emerg Med. 2020;75(1):13‐17. doi:10.1016/j.annemergmed.2019.04.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2019.04.020</ArticleId><ArticleId IdType="pmc">PMC6920606</ArticleId><ArticleId IdType="pubmed">31229387</ArticleId></ArticleIdList></Reference><Reference><Citation>Kline A, Williams JM, Steinberg ML, et al. Predictors of opioid overdose during the COVID‐19 pandemic: the role of relapse, treatment access and nonprescribed buprenorphine/naloxone. J Subst Use Addict Treat. 2023;149:209028. doi:10.1016/j.josat.2023.209028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.josat.2023.209028</ArticleId><ArticleId IdType="pmc">PMC10063455</ArticleId><ArticleId IdType="pubmed">37003539</ArticleId></ArticleIdList></Reference><Reference><Citation>Crystal S, Nowels M, Samples H, Olfson M, Williams AR, Treitler P. Opioid overdose survivors: medications for opioid use disorder and risk of repeat overdose in Medicaid patients. Drug Alcohol Depend. 2022;232:109269. doi:10.1016/j.drugalcdep.2022.109269</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugalcdep.2022.109269</ArticleId><ArticleId IdType="pmc">PMC8943804</ArticleId><ArticleId IdType="pubmed">35038609</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Onofrio G, O'Connor PG, Pantalon MV, et al. Emergency department‐initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313(16):1636‐1644. doi:10.1001/jama.2015.3474</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.3474</ArticleId><ArticleId IdType="pmc">PMC4527523</ArticleId><ArticleId IdType="pubmed">25919527</ArticleId></ArticleIdList></Reference><Reference><Citation>Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174. doi:10.1136/bmj.f174</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f174</ArticleId><ArticleId IdType="pmc">PMC4688551</ArticleId><ArticleId IdType="pubmed">23372174</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabatabai M, Cooper RL, Wilus DM, et al. The effect of naloxone access laws on fatal synthetic opioid overdose fatality rates. J Prim Care Community Health. 2023;14:21501319221147246. doi:10.1177/21501319221147246</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501319221147246</ArticleId><ArticleId IdType="pmc">PMC9834937</ArticleId><ArticleId IdType="pubmed">36625264</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh AK, Janke AT, Kinsman J, et al. Emergency department utilization for substance use disorders and mental health conditions during COVID‐19. PLoS One. 2022;17(1):e0262136. doi:10.1371/journal.pone.0262136</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0262136</ArticleId><ArticleId IdType="pmc">PMC8757912</ArticleId><ArticleId IdType="pubmed">35025921</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Donnell J, Gladden RM, Mattson CL, Hunter CT, Davis NL. Vital signs: characteristics of drug overdose deaths involving opioids and stimulants – 24 states and the District of Columbia, January‐June 2019. MMWR Morb Mortal Wkly Rep. 2020;69(35):1189‐1197. doi:10.15585/mmwr.mm6935a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6935a1</ArticleId><ArticleId IdType="pmc">PMC7470457</ArticleId><ArticleId IdType="pubmed">32881854</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and geographic patterns in drug and synthetic opioid overdose deaths—United States, 2013–2019. MMWR Morb Mortal Wkly Rep. 2021;70(6):202‐207. doi:10.15585/mmwr.mm7006a4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7006a4</ArticleId><ArticleId IdType="pmc">PMC7877587</ArticleId><ArticleId IdType="pubmed">33571180</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivolo‐Kantor AM, Hoots BE, Scholl L, et al. Nonfatal drug overdoses treated in emergency departments—United States, 2016–2017. MMWR Morb Mortal Wkly Rep. 2020;69(13):371‐376. doi:10.15585/mmwr.mm6913a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6913a3</ArticleId><ArticleId IdType="pmc">PMC7119520</ArticleId><ArticleId IdType="pubmed">32240125</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaudoin FL, Jacka BP, Li Y, et al. Effect of a peer‐led behavioral intervention for emergency department patients at high risk of fatal opioid overdose: a randomized clinical trial. JAMA Netw Open. 2022;5(8):e2225582. doi:10.1001/jamanetworkopen.2022.25582</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.25582</ArticleId><ArticleId IdType="pmc">PMC9364125</ArticleId><ArticleId IdType="pubmed">35943744</ArticleId></ArticleIdList></Reference><Reference><Citation>Maroko AR, Doan TM, Arno PS, Hubel M, Yi S, Viola D. Integrating social determinants of health with treatment and prevention: a new tool to assess local area deprivation. Prev Chronic Dis. 2016;13:E128. doi:10.5888/pcd13.160221</Citation><ArticleIdList><ArticleId IdType="doi">10.5888/pcd13.160221</ArticleId><ArticleId IdType="pmc">PMC5027849</ArticleId><ArticleId IdType="pubmed">27634778</ArticleId></ArticleIdList></Reference><Reference><Citation>
Control CfD
. drug overdose mortality by state. https://www.cdc.gov/nchs/pressroom/sosmap/drug_poisoning_mortality/drug_poisoning.htm
</Citation></Reference><Reference><Citation>Palumbo SA, Adamson KM, Krishnamurthy S, et al. Assessment of probable opioid use disorder using electronic health record documentation. JAMA Netw Open. 2020;3(9):e2015909. doi:10.1001/jamanetworkopen.2020.15909</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.15909</ArticleId><ArticleId IdType="pmc">PMC7489858</ArticleId><ArticleId IdType="pubmed">32886123</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis RJ, Wang Z, Genes N, Ma'ayan A. Predicting opioid dependence from electronic health records with machine learning. BioData Min. 2019;12:3. doi:10.1186/s13040-019-0193-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13040-019-0193-0</ArticleId><ArticleId IdType="pmc">PMC6352440</ArticleId><ArticleId IdType="pubmed">30728857</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan MD, Edlund MJ, Fan MY, DeVries A, Braden JB, Martin BC. Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: the TROUP study. Pain. 2010;150(2):332‐339. doi:10.1016/j.pain.2010.05.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2010.05.020</ArticleId><ArticleId IdType="pmc">PMC2897915</ArticleId><ArticleId IdType="pubmed">20554392</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrell DS, Cronkite D, Palmer RE, et al. Using natural language processing to identify problem usage of prescription opioids. Int J Med Inform. 2015;84(12):1057‐1064. doi:10.1016/j.ijmedinf.2015.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2015.09.002</ArticleId><ArticleId IdType="pubmed">26456569</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirle L, Jeffery A, Yaqoob A, Sanchez‐Roige S, Samuels DC. Two data‐driven approaches to identifying the spectrum of problematic opioid use: a pilot study within a chronic pain cohort. Int J Med Inform. 2021;156:104621. doi:10.1016/j.ijmedinf.2021.104621</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2021.104621</ArticleId><ArticleId IdType="pmc">PMC8609775</ArticleId><ArticleId IdType="pubmed">34673309</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice JB, White AG, Birnbaum HG, Schiller M, Brown DA, Roland CL. A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. Pain Med. 2012;13(9):1162‐1173. doi:10.1111/j.1526-4637.2012.01450.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1526-4637.2012.01450.x</ArticleId><ArticleId IdType="pubmed">22845054</ArticleId></ArticleIdList></Reference><Reference><Citation>Dwyer K, Walley AY, Langlois BK, et al. Opioid education and nasal naloxone rescue kits in the emergency department. West J Emerg Med. 2015;16(3):381‐384. doi:10.5811/westjem.2015.2.24909</Citation><ArticleIdList><ArticleId IdType="doi">10.5811/westjem.2015.2.24909</ArticleId><ArticleId IdType="pmc">PMC4427207</ArticleId><ArticleId IdType="pubmed">25987910</ArticleId></ArticleIdList></Reference><Reference><Citation>Green TC, Dauria EF, Bratberg J, Davis CS, Walley AY. Orienting patients to greater opioid safety: models of community pharmacy‐based naloxone. Harm Reduct J. 2015;12:25. doi:10.1186/s12954-015-0058-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12954-015-0058-x</ArticleId><ArticleId IdType="pmc">PMC4527253</ArticleId><ArticleId IdType="pubmed">26245865</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffin PO, Sullivan SD. Cost‐effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013;158(1):1‐9. doi:10.7326/0003-4819-158-1-201301010-00003</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-158-1-201301010-00003</ArticleId><ArticleId IdType="pubmed">23277895</ArticleId></ArticleIdList></Reference><Reference><Citation>Walley AY, Doe‐Simkins M, Quinn E, Pierce C, Xuan Z, Ozonoff A. Opioid overdose prevention with intranasal naloxone among people who take methadone. J Subst Abuse Treat. 2013;44(2):241‐247. doi:10.1016/j.jsat.2012.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsat.2012.07.004</ArticleId><ArticleId IdType="pubmed">22980450</ArticleId></ArticleIdList></Reference><Reference><Citation>Dora‐Laskey A, Kellenberg J, Dahlem CH, et al. Piloting a statewide emergency department take‐home naloxone program: improving the quality of care for patients at risk of opioid overdose. Acad Emerg Med. 2022;29(4):442‐455. doi:10.1111/acem.14435</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acem.14435</ArticleId><ArticleId IdType="pubmed">34962682</ArticleId></ArticleIdList></Reference><Reference><Citation>Tse WC, Djordjevic F, Borja V, et al. Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a ‘moral hazard’ associated with naloxone supply. Int J Drug Policy. 2022;100:103513. doi:10.1016/j.drugpo.2021.103513</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugpo.2021.103513</ArticleId><ArticleId IdType="pubmed">34798434</ArticleId></ArticleIdList></Reference><Reference><Citation>Papp J, Vallabhaneni M, Morales A, Schrock JW. Take ‐home naloxone rescue kits following heroin overdose in the emergency department to prevent opioid overdose related repeat emergency department visits, hospitalization and death‐ a pilot study. BMC Health Serv Res. 2019;19(1):957. doi:10.1186/s12913-019-4734-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-019-4734-5</ArticleId><ArticleId IdType="pmc">PMC6907348</ArticleId><ArticleId IdType="pubmed">31829228</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers LC, Hallowell BD, Samuels EA, Daly M, Baird J, Beaudoin FL. An evaluation of the association between specific post‐overdose care services in emergency departments and subsequent treatment engagement. J Am Coll Emerg Physicians Open. 2023;4(1):e12877. doi:10.1002/emp2.12877</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emp2.12877</ArticleId><ArticleId IdType="pmc">PMC9833281</ArticleId><ArticleId IdType="pubmed">36643599</ArticleId></ArticleIdList></Reference><Reference><Citation>Sindhwani MK, Friedman A, O'Donnell M, Stader D, Weiner SG. Naloxone distribution programs in the emergency department: a scoping review of the literature. J Am Coll Emerg Physicians Open. 2024;5(3):e13180. doi:10.1002/emp2.13180</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emp2.13180</ArticleId><ArticleId IdType="pmc">PMC11079430</ArticleId><ArticleId IdType="pubmed">38726467</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardin J, Seltzer J, Galust H, et al. Emergency department take‐home naloxone improves access compared with pharmacy‐dispensed naloxone. J Emerg Med. 2024;66(4):e457‐e462. doi:10.1016/j.jemermed.2023.11.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2023.11.020</ArticleId><ArticleId IdType="pubmed">38461132</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Onofrio G, Chawarski MC, O'Connor PG, et al. Emergency department‐initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention. J Gen Intern Med. 2017;32(6):660‐666. doi:10.1007/s11606-017-3993-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-017-3993-2</ArticleId><ArticleId IdType="pmc">PMC5442013</ArticleId><ArticleId IdType="pubmed">28194688</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein E, Edwards E, Dorfman D, Heeren T, Bliss C, Bernstein J. Screening and brief intervention to reduce marijuana use among youth and young adults in a pediatric emergency department. Acad Emerg Med. 2009;16(11):1174‐1185. doi:10.1111/j.1553-2712.2009.00490.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1553-2712.2009.00490.x</ArticleId><ArticleId IdType="pmc">PMC2910362</ArticleId><ArticleId IdType="pubmed">20053238</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein SL, D'Onofrio G, Rosner J, et al. Successful tobacco dependence treatment in low‐income emergency department patients: a randomized trial. Ann Emerg Med. 2015;66(2):140‐147. doi:10.1016/j.annemergmed.2015.03.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2015.03.030</ArticleId><ArticleId IdType="pmc">PMC4819432</ArticleId><ArticleId IdType="pubmed">25920384</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy‐Byrne P, Bumgardner K, Krupski A, et al. Brief intervention for problem drug use in safety‐net primary care settings: a randomized clinical trial. JAMA. 2014;312(5):492‐501. doi:10.1001/jama.2014.7860</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.7860</ArticleId><ArticleId IdType="pmc">PMC4599980</ArticleId><ArticleId IdType="pubmed">25096689</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogenschutz MP, Donovan DM, Mandler RN, et al. Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial. JAMA Intern Med. 2014;174(11):1736‐1745. doi:10.1001/jamainternmed.2014.4052</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2014.4052</ArticleId><ArticleId IdType="pmc">PMC4238921</ArticleId><ArticleId IdType="pubmed">25179753</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein SL, D'Onofrio G. Screening, treatment initiation, and referral for substance use disorders. Addict Sci Clin Pract. 2017;12(1):18. doi:10.1186/s13722-017-0083-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13722-017-0083-z</ArticleId><ArticleId IdType="pmc">PMC5545867</ArticleId><ArticleId IdType="pubmed">28780906</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuels EA, Baird J, Yang ES, Mello MJ. Adoption and utilization of an emergency department naloxone distribution and peer recovery coach consultation program. Acad Emerg Med. 2019;26(2):160‐173. doi:10.1111/acem.13545</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acem.13545</ArticleId><ArticleId IdType="pubmed">30074673</ArticleId></ArticleIdList></Reference><Reference><Citation>Avalone L, Lalane M, King C, Pfeiffer K, Linn‐Walton R, Barron C. Integrating substance use peer support and screening brief intervention and referral to treatment services in the emergency department: a descriptive study of the ED leads program. Addict Sci Clin Pract. 2024;19(1):15. doi:10.1186/s13722-024-00445-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13722-024-00445-x</ArticleId><ArticleId IdType="pmc">PMC10902983</ArticleId><ArticleId IdType="pubmed">38419101</ArticleId></ArticleIdList></Reference><Reference><Citation>Snyder H, Kalmin MM, Moulin A, et al. Rapid adoption of low‐threshold buprenorphine treatment at California emergency departments participating in the CA Bridge Program. Ann Emerg Med. 2021;78(6):759‐772. doi:10.1016/j.annemergmed.2021.05.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2021.05.024</ArticleId><ArticleId IdType="pubmed">34353655</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson ES, Rusoja E, Luftig J, et al. Effectiveness of substance use navigation for emergency department patients with substance use disorders: an implementation study. Ann Emerg Med. 2023;81(3):297‐308. doi:10.1016/j.annemergmed.2022.09.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2022.09.025</ArticleId><ArticleId IdType="pubmed">36402631</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>